a retrospective cohort study at a tertiary centre in India to study Effect of Anti- SSA/Ro and Anti SSB /La antibodies on obstetric and perinatal outcomes â??
Not Applicable
- Conditions
- Health Condition 1: O359- Maternal care for (suspected) fetal abnormality and damage, unspecified
- Registration Number
- CTRI/2022/04/041676
- Lead Sponsor
- Amrita Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Anti -Ro/anti-La antibodies positive pregnant women
2)Age more than 18 years
Exclusion Criteria
1) Pregnancies occurring before diagnosis of disease
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess Obstetric and perinatal outcomes in women with anti-Ro/anti-La positive <br/ ><br>antibodies . <br/ ><br>Neonates with Heart block, neonatal lupus at full term <br/ ><br>IUGR , Oligo amnios, doppler changes before term <br/ ><br>Medical termination of pregancy in first trimester <br/ ><br>Timepoint: First TRrimester pregnancy for fetal loss <br/ ><br>Third trimester for preterm <br/ ><br>After delivery for Neonatal outcomes <br/ ><br>
- Secondary Outcome Measures
Name Time Method ilTimepoint: nil